Home/Acticor Biotech/Gilles Avenard
GA

Gilles Avenard

Chief Executive Officer

Acticor Biotech

Therapeutic Areas

Acticor Biotech Pipeline

DrugIndicationPhase
Glenzocimab (ACT017)Acute Ischemic StrokePhase 2/3